GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (OTCPK:SBMJF) » Definitions » Machinery, Furniture, Equipment

SBMJF (Dimerix) Machinery, Furniture, Equipment : $0.01 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Dimerix Machinery, Furniture, Equipment?

Dimerix's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was $0.01 Mil.

Dimerix's quarterly Machinery, Furniture, Equipment declined from Dec. 2022 ($0.01 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($0.01 Mil).


Dimerix Machinery, Furniture, Equipment Historical Data

The historical data trend for Dimerix's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimerix Machinery, Furniture, Equipment Chart

Dimerix Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Machinery, Furniture, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dimerix Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 - 0.01 -

Dimerix Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Dimerix Business Description

Industry
Traded in Other Exchanges
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Dimerix Headlines

From GuruFocus

DIMERIX's DMX-200 Posts Strong Results in Kidney Disease Trial

By Business Wire Business Wire 07-29-2020